Literature DB >> 24560543

Increased requirement for minute ventilation and negative arterial to end-tidal carbon dioxide gradient may indicate malignant hyperthermia.

Ho-Tien Lin1, Shen-Chih Wang1, Zhiyi Zuo2, Mei-Yung Tsou1, Kwok-Hon Chan1, Hui-Bih Yuan3.   

Abstract

Characteristic signs of malignant hyperthermia (MH) include unexplained tachycardia, increased end-tidal carbon dioxide (Etco₂) concentration, metabolic and respiratory acidosis, and an increase in body temperature above 38.8°C. We present the case of a patient with highly probable MH. In addition to sinus tachycardia and metabolic and respiratory acidosis, this patient also had a negative arterial to Etco₂ gradient and an increased requirement for minute ventilation to maintain a normal Etco₂ concentration, with signs of increased CO₂ production. Despite these signs of MH, the patient's rectal temperature monitoring equipment did not show an increase in temperature, although the temperature measured in the mouth was increased. This case illustrates the unreliability of measuring rectal temperature as a means of reflecting body temperature during MH and the usefulness of increased CO₂ production signs in helping to diagnose MH.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  blood gas analysis; body temperature; capnography; malignant hyperthermia; pulmonary ventilation

Mesh:

Substances:

Year:  2014        PMID: 24560543     DOI: 10.1016/j.jcma.2014.01.002

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  2 in total

1.  JSA guideline for the management of malignant hyperthermia crisis 2016.

Authors: 
Journal:  J Anesth       Date:  2017-02-28       Impact factor: 2.078

2.  Mind the gap!!: Reversal of arterial to end-tidal CO2 gradient in thoracoscopic bronchogenic cyst excision.

Authors:  Priyanka Pradeep Karnik; Ketan S Kulkarni; Nandini Malay Dave; Madhu Garasia
Journal:  Indian J Anaesth       Date:  2017-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.